TP53 and breast carcinoma: Although a larger number of breast cancer cell lines should be tested, this initial study suggests that the apoptotic effect of this combination might be independent of the mutational status of the p53 gene and the levels of expression of the estrogen receptor-α (ERα), two genes/proteins that determine the sensitivity or resistance of breast cancer cells to apoptosis [17], [18].